STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Moberg Pharma AB announces that the company’s Nomination Committee has decided to present the following proposal to the Annual General Meeting 2016.
The Nomination Committee
The Nomination Committee comprises of Per-Olof Edin (chairman) representing Östersjöstiftelsen, Katja Bergqvist representing Handelsbanken Fonder, Anders Rodebjer representing Wolco Invest och Mats Pettersson, chairman of the Board of Directors of the company.
